I recommend it to everyone who wants to feel a little bit of a puckered lip
In research settings this pathway triad is studied for effects on appetite signals, gastric emptying, insulin dynamics, and energy expenditure
1 However, if you also take sulfonylureas or insulin, your risk is higher
Doctors, patients, and drug companies can all submit reports to these systems
If you: Have contraindications or complex medical needs requiring in-person care Strongly prefer FDA-approved medications and can access them affordably Want comprehensive support beyond medication (nutrition counseling, behavioral therapy, etc.) Are uncomfortable with the regulatory uncertainty around compounded GLP-1s Cannot commit to long-term treatment costs and requirements Then other pathways - in-person obesity medicine, bariatric surgery evaluation, or continued lifestyle-based approaches with professional support - may serve you better
Animal studies showed developmental risks